{
  "label": "clinical_signal_03_dx_renal_biomarker_study_003",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:830be3e0c372314869658fefea265a75bb71c4814ba47a021cca1b03379819e7",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:56:30.118943",
  "content": "## 2024-03-18 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 54\n- Active: 54\n- Screen Failures Cumulative: 6\n- Withdrawals Cumulative: 0\n\n### Enrollment By Cohort\n- 10mg: 10\n- 25mg: 13\n- 50mg: 15\n- 100mg: 16\n\n### Biomarkers By Cohort\n#### 10mg\n- KIM-1 (ng/mL) Mean: 1.58\n- KIM-1 (ng/mL) SD: 0.38\n- NGAL (ng/mL) Mean: 56.7\n- NGAL (ng/mL) SD: 18.6\n- Cystatin C (mg/L) Mean: 0.84\n- Cystatin C (mg/L) SD: 0.1\n- eGFR (mL/min) Mean: 63.6\n- eGFR (mL/min) SD: 9.0\n- UACR (mg/g) Mean: 57.4\n- UACR (mg/g) SD: 32.9\n- Serum Creatinine (mg/dL) Mean: 1.12\n- Serum Creatinine (mg/dL) SD: 0.17\n- Urine Protein (mg/dL) Mean: 36.6\n- Urine Protein (mg/dL) SD: 5.2\n- Urine Output (mL/24h) Mean: 1971\n- Urine Output (mL/24h) SD: 361\n\n#### 25mg\n- KIM-1 (ng/mL) Mean: 1.06\n- KIM-1 (ng/mL) SD: 0.47\n- NGAL (ng/mL) Mean: 83.4\n- NGAL (ng/mL) SD: 14.3\n- Cystatin C (mg/L) Mean: 1.07\n- Cystatin C (mg/L) SD: 0.11\n- eGFR (mL/min) Mean: 52.4\n- eGFR (mL/min) SD: 9.7\n- UACR (mg/g) Mean: 89.0\n- UACR (mg/g) SD: 31.5\n- Serum Creatinine (mg/dL) Mean: 1.21\n- Serum Creatinine (mg/dL) SD: 0.21\n- Urine Protein (mg/dL) Mean: 32.0\n- Urine Protein (mg/dL) SD: 3.7\n- Urine Output (mL/24h) Mean: 1794\n- Urine Output (mL/24h) SD: 312\n\n#### 50mg\n- KIM-1 (ng/mL) Mean: 2.72\n- KIM-1 (ng/mL) SD: 0.38\n- NGAL (ng/mL) Mean: 64.1\n- NGAL (ng/mL) SD: 17.5\n- Cystatin C (mg/L) Mean: 0.84\n- Cystatin C (mg/L) SD: 0.09\n- eGFR (mL/min) Mean: 57.7\n- eGFR (mL/min) SD: 9.4\n- UACR (mg/g) Mean: 80.1\n- UACR (mg/g) SD: 30.2\n- Serum Creatinine (mg/dL) Mean: 1.41\n- Serum Creatinine (mg/dL) SD: 0.28\n- Urine Protein (mg/dL) Mean: 16.9\n- Urine Protein (mg/dL) SD: 9.4\n- Urine Output (mL/24h) Mean: 1758\n- Urine Output (mL/24h) SD: 305\n\n#### 100mg\n- KIM-1 (ng/mL) Mean: 1.59\n- KIM-1 (ng/mL) SD: 0.28\n- NGAL (ng/mL) Mean: 95.0\n- NGAL (ng/mL) SD: 9.5\n- Cystatin C (mg/L) Mean: 1.03\n- Cystatin C (mg/L) SD: 0.12\n- eGFR (mL/min) Mean: 51.5\n- eGFR (mL/min) SD: 13.9\n- UACR (mg/g) Mean: 85.1\n- UACR (mg/g) SD: 18.1\n- Serum Creatinine (mg/dL) Mean: 1.33\n- Serum Creatinine (mg/dL) SD: 0.23\n- Urine Protein (mg/dL) Mean: 22.3\n- Urine Protein (mg/dL) SD: 7.8\n- Urine Output (mL/24h) Mean: 1774\n- Urine Output (mL/24h) SD: 396\n\n### Dose Response\n- KIM-1 Dose Correlation (r): 0.565\n- NGAL Dose Correlation (r): 0.261\n- eGFR Dose Correlation (r): -0.348\n- UACR Dose Correlation (r): 0.24\n\n### Safety Labs\n- Hemoglobin (g/dL) Mean: 14.6\n- Hemoglobin (g/dL) SD: 1.0\n- Hematocrit (%) Mean: 39.2\n- Hematocrit (%) SD: 3.7\n- WBC (k/\u00b5L) Mean: 8.1\n- WBC (k/\u00b5L) SD: 1.2\n- Platelets (k/\u00b5L) Mean: 214\n- Platelets (k/\u00b5L) SD: 45\n- Sodium (mEq/L) Mean: 138.3\n- Sodium (mEq/L) SD: 2.3\n- Potassium (mEq/L) Mean: 4.1\n- Potassium (mEq/L) SD: 0.3\n- Bicarbonate (mEq/L) Mean: 26.4\n- Bicarbonate (mEq/L) SD: 2.9\n- Phosphorus (mg/dL) Mean: 3.3\n- Phosphorus (mg/dL) SD: 0.5\n\n### Adverse Events\n- AE ID: RB-AE-0306, Description: dizziness, Grade: 1, Relatedness: possibly related, Resolved: true, Cohort: 25mg\n- AE ID: RB-AE-0336, Description: headache, Grade: 1, Relatedness: not related, Resolved: true, Cohort: 50mg\n\n### Protocol Deviations\n- PD ID: RB-PD-0332, Description: Urine sample collection outside 24h window, Severity: moderate\n- PD ID: RB-PD-0330, Description: Dose adjustment documentation incomplete, Severity: moderate\n\n### Events\n- Central lab urine biomarker batch analysis completed for Week 3\n- DSMB safety data snapshot prepared\n- Central lab urine biomarker batch analysis completed for Week 3\n\n### Notes\n- Week 3: Renal biomarker collection on schedule. 54 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 3,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}